Study Type
Interventional - Procedure
completed
The objective of RADIAL PROTECTION was to assess the utility of using a novel radiation protection lead shield in reducing radiation exposure that interventional cardiologists receive during Coronary Angiography or Percutaneous Coronary Intervention (PCI) procedures.
Participants were allocated to one of the following groups: The procedure as done routinely with or without the lead shield use (current standard practice); Interventional cardiologists who will perform the procedure will wear a radiation protection cap in all procedures.
Primary Endpoint – Lead Shield Comparison
1. Difference between both groups in total radiation dose (?Sv) that the interventional cardiologist got exposed to as read by the dosimeters at left breast, and
2. Difference between both groups in radiation dose that the interventional cardiologist got exposed to divided by Air Kerma (?Sv/mGy).
Study Design
RCT
NO. of Countries
1
NO. of Sites
1
NO. of Participants
230
Study Period
2012 - 2014
Sponsor
PHRI
Sanjit Jolly
Scientist
Sanjit Jolly
Scientist
Sanjit Jolly is an interventional cardiologist at Hamilton Health Sciences and associate professor at McMaster University. He has formal training in clinical trials with a M.Sc. in Health Research Methodology from McMaster. He was the principal investigator of the RIVAL trial, a randomized trial of 7021 patients comparing radial and femoral access for coronary intervention. He is also the principal investigator trial of the ongoing TOTAL trial, an international randomized trial (N=10,700) of thrombectomy during primary PCI.
